MLYS

Conviction 26HealthcareScan · Thu, Jun 25, 2026

Three white soldiers

MLYS$26.33+2.15%

ResistanceSupportVol 14Insider sell

Vol MA14 2.04M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Mineralys Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSmineralystx.com ↗

Price26.33

Change+2.15%

Gap-0.10%

Rel volume0.95×

Avg volume2.22M

Avg $ vol56.2M

SMA 2025.78

SMA 5027.49

SMA 20032.94

Price vs 50-4.23%

Price vs 200-20.07%

MA stackbearish

50/200 cross—

Supertrenddown · 28.23

RSI (14)51

MACD hist0.25

MACD crossbull · 2d

Stoch %K / %D91 / 83

ADX (14)19

+DI / −DI23 / 23

RSI divergence—

MACD divergence—

ATR %+5.57%

ADR %5.53%

52w high47.33

52w low12.87

From 52w high-44.37%

Above 52w low+104.58%

New 52w highNo

SqueezeOff

Bollinger width41.57%

%B0.55

Donchian pos40.96%

Donchian high32.14

Donchian low22.30

AVWAP (52w high)30.86

vs AVWAP high-14.69%

AVWAP (52w low)31.80

vs AVWAP low-17.19%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d0.95×

Avg vol (14d)2.04M

Avg vol (20d)2.22M

Avg $ vol (20d)56.2M

Market cap2.17B

RS 3m (vs SPY)+0.40%

RS 6m (vs SPY)-37.75%

RS line new highNo

Trend template3/8

Technical rank22.2

1 week+4.78%

1 month-12.20%

3 months+6.95%

6 months-29.90%

1 year+86.21%

YTD-26.27%

P/E-14.05

P/B3.40

P/S—

P/FCF-15.25

EPS-2.29

Div yield—

ROE-24.23%

ROA-23.69%

Debt/Eq—

Current44.33

EV/EBITDA-12.08

Gross margin—

Net margin—

Rev growth—

EPS growth13.02%

Price target50.40

Target upside91.42%

Analyst ratingBuy

Institutional107.56%

Ent. value2.06B

Revenue—

Net income-39.34M

Gross profit—

Free cash flow-142.43M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out82.5M

Employees76

ListedFri, Feb 10, 2023

Free float50.59M

Float %63.9%

Short interest9.48M

Days to cover6.8d

Short volume55.3%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.47 vs −$0.51

Last surprise+7.8% beat

Setup gradeD

Conviction26 / 100

Pattern quality—

Tech rank22.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MLYS

All disclosures →

No recent disclosed trades by Congress in MLYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MLYS · 3 buys · 7 sells

Insider	Side	Shares	Value	Traded	Filed
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-18	Exercise	417	$6K	2026-05-18	2026-05-19
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-05-18	Exercise	417	$0	2026-05-18	2026-05-19
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-18	Sell	417	$11K	2026-05-18	2026-05-19
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-05-13	Exercise	3.54K	$0	2026-05-13	2026-05-13
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-13	Exercise	3.54K	$36K	2026-05-13	2026-05-13
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-05-13	Exercise	4.17K	$0	2026-05-13	2026-05-13
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-13	Exercise	4.17K	$59K	2026-05-13	2026-05-13
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-13	Sell	14.06K	$402K	2026-05-13	2026-05-13
Rodman David Malcom Chief Medical Officer · Stock Option · 2026-05-12	Exercise	6.35K	$0	2026-05-12	2026-05-13
Rodman David Malcom Chief Medical Officer · Common Stock · 2026-05-12	Sell	6.35K	$186K	2026-05-12	2026-05-13

SEC filings

EDGAR filings in MLYS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.